Cargando…
From signalling pathways to targeted therapies: unravelling glioblastoma’s secrets and harnessing two decades of progress
Glioblastoma, a rare, and highly lethal form of brain cancer, poses significant challenges in terms of therapeutic resistance, and poor survival rates for both adult and paediatric patients alike. Despite advancements in brain cancer research driven by a technological revolution, translating our und...
Autores principales: | Dewdney, Brittany, Jenkins, Misty R., Best, Sarah A., Freytag, Saskia, Prasad, Krishneel, Holst, Jeff, Endersby, Raelene, Johns, Terrance G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587102/ https://www.ncbi.nlm.nih.gov/pubmed/37857607 http://dx.doi.org/10.1038/s41392-023-01637-8 |
Ejemplares similares
-
Anoctamins and Calcium Signalling: An Obstacle to EGFR Targeted Therapy in Glioblastoma?
por: Dewdney, Brittany, et al.
Publicado: (2022) -
Synthetic biology, genetic circuits and machine learning: a new age of cancer therapy
por: Prasad, Krishneel, et al.
Publicado: (2023) -
A Pre-Clinical Assessment of the Pan-ERBB Inhibitor Dacomitinib in Pediatric and Adult Brain Tumors
por: Endersby, Raelene, et al.
Publicado: (2018) -
Harnessing the immune system in glioblastoma
por: Brown, Nicholas F., et al.
Publicado: (2018) -
Harnessing the Secret Structure of Innovation
por: Reeves, Martin
Publicado: (2017)